GENINVO Trademark

Trademark Overview


On Thursday, August 14, 2025, a trademark application was filed for GENINVO with the United States Patent and Trademark Office. The USPTO has given the GENINVO trademark a serial number of 99338269. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, February 10, 2026. This trademark is owned by GenInvo, Inc.. The GENINVO trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:

Providing temporary use of online non-downloadable software and software applications for data management and data analysis in the nature of clinical trial data ingestion, data anonymization, data collaboration, data transformation, predictive data analysis, document review, metadata management, patient data anonymization, and automated reporting; providing temporary use of online non-downloadable software and software applications using artificial intelligence (AI) for data management and data analysis in the nature of clinical trial data ingestion, data anonymization, data collaboration, data transformation, predictive data analysis, document review, metadata management, patient data anonymization, and automated reporting; Custom design of computer application software; Technical support services, namely, cloud managed services in the nature of remote infrastructure management services for migration, configuration, monitoring, and management of cloud computing IT systems and cloud da...

Business consulting services for pharmaceutical and life sciences companies in the fields of clinical research, clinical trials, and applications for drug approval; Business data analytics and business data management services in the pharmaceutical and life sciences fields of clinical research; Business consulting and management in the field of clinical trials, namely, clinical data management on behalf of pharmaceutical and life sciences companies to assist them with clinical research and clinical trials; Providing independent review of clinical trial data for business purposes
geninvo

General Information


Serial Number99338269
Word MarkGENINVO
Filing DateThursday, August 14, 2025
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, February 10, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 10, 2026

Trademark Statements


Goods and ServicesProviding temporary use of online non-downloadable software and software applications for data management and data analysis in the nature of clinical trial data ingestion, data anonymization, data collaboration, data transformation, predictive data analysis, document review, metadata management, patient data anonymization, and automated reporting; providing temporary use of online non-downloadable software and software applications using artificial intelligence (AI) for data management and data analysis in the nature of clinical trial data ingestion, data anonymization, data collaboration, data transformation, predictive data analysis, document review, metadata management, patient data anonymization, and automated reporting; Custom design of computer application software; Technical support services, namely, cloud managed services in the nature of remote infrastructure management services for migration, configuration, monitoring, and management of cloud computing IT systems and cloud databases; Providing quality control services in the fields of clinical research, clinical trials, and applications for drug approval; Providing independent review of clinical trial data for medical or scientific purposes
Goods and ServicesBusiness consulting services for pharmaceutical and life sciences companies in the fields of clinical research, clinical trials, and applications for drug approval; Business data analytics and business data management services in the pharmaceutical and life sciences fields of clinical research; Business consulting and management in the field of clinical trials, namely, clinical data management on behalf of pharmaceutical and life sciences companies to assist them with clinical research and clinical trials; Providing independent review of clinical trial data for business purposes

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, August 14, 2025
Primary Code035
First Use Anywhere DateSunday, June 30, 2019
First Use In Commerce DateSunday, June 30, 2019

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 14, 2025
Primary Code042
First Use Anywhere DateSunday, June 30, 2019
First Use In Commerce DateSunday, June 30, 2019

Trademark Owner History


Party NameGenInvo, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBloomington, IL 61701

Party NameGenInvo, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBloomington, IL 61701

Trademark Events


Event DateEvent Description
Thursday, August 14, 2025NEW APPLICATION ENTERED
Thursday, August 14, 2025APPLICATION FILING RECEIPT MAILED
Tuesday, December 30, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 31, 2025ASSIGNED TO EXAMINER
Wednesday, December 31, 2025NON-FINAL ACTION WRITTEN
Wednesday, December 31, 2025NON-FINAL ACTION E-MAILED
Wednesday, December 31, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 13, 2026EXAMINERS AMENDMENT -WRITTEN
Tuesday, January 13, 2026EXAMINERS AMENDMENT E-MAILED
Tuesday, January 13, 2026NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, January 13, 2026EXAMINER'S AMENDMENT ENTERED
Tuesday, January 13, 2026APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 4, 2026NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 10, 2026PUBLISHED FOR OPPOSITION
Tuesday, February 10, 2026OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED